despit today modest declin expect stock grind higher
days/week come settl higher rang organ growth vs
consensu yoy margin expans importantli ih reiter
consid guid call commentari also posit
ih pivot commerci util data lake see servic cloud
transit note boost tp ev/ebitda
multipl amid option continu portfolio optim
analysi avail request enhanc capit return inaugur dividend like
recommend board jan balanc sheet strength cse net debt/ebitda
see continu out-performance market discount impress
organ growth margin expans recogn perceiv cyclic given
transport resourc exposur believ stock pois
outperform end market fundament price power cross-sel new product
innov amid mission-crit data asset embed within workflow take
ep model
buybacksincrement call commentari suggest inclus asr
addit vs cse potenti provid upsid
positivestransport organ revenu growth vs cse
recur transport amid amm cite contribut strong dd organ
growth recur organ growth benefit ipreo revenu
organ growth quarter cite expect capit return
come high-end capit return fcfprimarili via
buyback asr expect complet
convers percentag point one-
time tax payment anoth point denver campu invest tax
sale tmt busi cite challeng given note headwind
increasingli encourag product design last quarter
outperform tp impli ebitda vs rang averag
believ elev multipl reason market becom
comfort execut acceler growth profil bs improv risk
valuat metric
number share
 close
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
lead provid data analyt workflow solut
energi chemic econom transport financi
scenario predic organ growth
organ growth estim acquisit end market strength
drive out-performance believ result adj ebitda
growth cse drive increment
higher multipl impli tp
grey scenario predic organ growth deceler
end market deceler acquisit integr distract core
organ growth hurt margin ebitda revis lower
impli compress multipl neg affect
lower multipl impli tp
price
 close
compani mention price
kevin mcveigh certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view express
report
